semaglutide .25 side effects The letter cited three deaths among patients using semaglutide, the active ingredient in several of its weight-loss medications, which it said were not properly investigated or reported. Read more at the link FDA reviewing Ozempic, other diabetes

Read more In Case You Missed It Health Canada approved Rybelsus for heart disease prevention (January 2026) The oral semaglutide tablet now has an expanded indication to reduce cardiovascular risk in adults with Type 2 diabetes

Legal Representation : Firms like Powell & Majestro are pivotal in navigating these Novo Nordisk legal battles, offering legal recourse to those who might have suffered from Ozempic negligence claims

The FDA label includes a boxed warning regarding the risk of thyroid C-cell tumors observed in rodent studies

The 14 days ambulatory glucose profile (AGP) before the 18-month visit showed a time in range (TIR) of 94%, a time below range (TBR) of 3%, and a time above range (TAR) of 3%, time with active data 71%, glucose management indicator (GMI) 41 mmol/mol and coefficient of variation (CV) 23.5%

Homozygous mutations may result in more significant disruptions in methylation

Identification of a novel Raf-1 pathway activator that inhibits gastrointestinal carcinoid cell growth